A Phase 3 interventional study of PET scan and MRI in Multiple Myeloma, sponsored by Nantes University Hospital. Completed at 17 sites in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-14.
Sponsored by Nantes University Hospital · Phase 3, Interventional, and Diagnostic
Multicenter open-label prospective comparative study of PET-scan and MRI at the time of diagnosis, after 3 cycles of induction therapy (RVD) and at the completion of therapy.
3,632 studies on the registry are indexed under Multiple Myeloma; 745 are open to participants now.
This study's enrollment of 152 is above the median of 41 across 2,907 interventional studies indexed under Multiple Myeloma.
Browse Multiple Myeloma studies →Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Performed at diagnosis, after 3 cycles of induction therapy, and at completion of therapy
Performed at diagnosis, after 3 cycles of induction therapy, and at completion of therapy
Number of patients with at least one lesion not detected on the MRI lesions
Time frame: At diagnosis
Negativity of the exam after 3 cycles of chemotherapy and just before the maintenance treatment
Time frame: 3 months and 7 months
Number of lesions at diagnosis
Time frame: Inclusion (diagnosis)
diffuse disease at diagnosis
Time frame: Diagnosis time (inclusion)
Direct costs of PET and MRI at diagnosis, after the first cycles of chemotherapy and before the maintenance treatment
Time frame: Inclusion, 3 months and 7 months
This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nantes University Hospital